SpineSmith Acquires Rights to Tissue Genesis Stem Cell Isolating Technology for Diagnosis and Treatment of the Human Spine

SpineSmith Partners, LP acquired rights in spine for Tissue Genesis, Inc.'s adipose (fat) tissue derived cell technology. Tissue Genesis' TGI 100 cell isolation kits and TGI 1000 automated cell isolation systems will rapidly process autologous (patient-derived) adipose tissue and isolate large quantities of regenerative cells, which can be utilized to treat a number of spine related diseases (


SpineSmith Acquires Rights to Tissue Genesis Stem Cell Isolating Technology for Diagnosis and Treatment of the Human Spine



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***